Reimbursement Pathways hires Michael F. High as Director of Reimbursement Services
Lancaster, PA, October 1, 2018 – Reimbursement Pathways is pleased to announce the hiring of Michael F. High as Director of Reimbursement Services. With significant experience in contract negotiations, insurance, and reimbursement, Michael will enhance our healthcare consulting services.
Michael is an experienced healthcare professional with more than 20 years of experience. Throughout his career, Michael has focused on reimbursement, strategic planning, cost savings analysis, claims analysis, pricing, contract negotiations, value-based healthcare, budgeting, accounting, and building financial models in the healthcare insurance industry.
Prior to joining Reimbursement Pathways, Michael gained extensive experience in reimbursement as the Manager of Reimbursement for Independent Blue Cross. Earlier in his career, he served as a Senior Healthcare Consultant for Coventry Healthcare. Michael also worked as the Senior Financial Analyst and Senior Systems Analyst at Provident American Corporate/HealthAxis.com. While with Provident American Corporate, he helped the company transform from an insurance company into a broker of insurance over the internet.
“The healthcare industry is evolving, and physicians face the difficultly of negotiating reimbursements in addition to their clinical demands. Michael will be a great resource for our clients as they strive to achieve their greatest financial success,” said Dr. Christopher Rumpf, Chief Clinical Officer.
Steeped in industry best practice policies and procedures, Reimbursement Pathways is dedicated to addressing real-world issues facing healthcare providers through simple solutions. Our team of professionals focuses on optimizing contract management processes to create significant cost savings and maximizing payer fee-for-service and fee-for-value reimbursements to enhance cash flow and create new revenue streams. In short, we partner with you to ensure you achieve your greatest financial success.